Tenuate retard (buy Diethylpropion Amfepramone)

(1 customer review)


Box : 60 pills
manufacturer : germany
shipping : 2-4 working days

Choose an option
QTY: 2 Boxes 120 pills
QTY: 3 Boxes 180 pills
QTY: 10 Boxes 600 pills
QTY: 20 Boxes 1200 pills
SKU: RERETAR Category:


Tenuate retard ( Diethylpropion Amfepramone )

Tenuate retard is an appetite suppressant similar to an amphetamine.  includes diethylpropion hydrochloride as the primary active ingredient.




Adult: 25 mg tid or 75 mg once daily in mid-morning as a modified-release preparation.

Ingredient matches for Tenuate Amfepramone


Amfepramone hydrochloride (a derivative of Amfepramone) is reported as an ingredient of Tenuate pills in the following countries:

  • Germany

Who Should Avoid Using Tenuate?

The active ingredient in Tenuate has been linked to a number of possible interactions with existing health conditions that a customer might have been diagnosed with previously. so In particular, the official leaflet4 of this product advised patients to completely avoid the use of this drug if they have been diagnosed with any of the following medical conditions:

  • Advanced arteriosclerosis
  • Severe hypertension
  • Hypersensitivity to sympathomimetic amines
  • Pulmonary hypertension
  • Glaucoma

How Tenuate Should Be Used For Maximum Efficiency

Patients who are interested in using Tenuate for a pharmaceutical approach to treating their obesity need to be aware of the fact that this drug alone will not produce appropriate results. For this drug to be effective, a patient will need to reduce their caloric intake (this is where this drug comes into play) and ensure they perform an adequate amount of physical exercise that causes them to exert more calories than what they are consuming.

Additional information


10 Boxes 600 pills, 2 Boxes 120 pills, 20 Boxes 1200 pills, 3 Boxes 180 pills

1 review for Tenuate retard (buy Diethylpropion Amfepramone)

  1. robert

    Awesome post! Keep up the great work!

Add a review

Your email address will not be published. Required fields are marked *